Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2020-11-03
2022-12-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Laparoscopic-lavage Observational Study
NCT02662088
Colectomy for Cancer in the Elderly by Laparoscopy or Laparotomy
NCT03033719
Surgical-Site Infection After Laparoscopic Right Colectomy
NCT04350203
Quality of Life (QOL) After Elective Sigmoidectomy for Diverticular Diseases (DIVERTI)
NCT04730765
Laparoscopic Versus Open Left Colonic Resection
NCT00894725
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In accordance with the recommendations on ERAS published by the HAS, a program involving pre-, per- and post-interventional investment, has been put in place. Patients are discharged on D0, followed by close monitoring by a home care nurse twice daily. This nurse is in charge of collecting clinical data in order to detect possible early signs of post-operative complications that would justify re-hospitalisation after a medical-surgical decision.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
outpatient left laparoscopic colectomy
Left laparoscopic laparoscopic colectomy patient managed on an outpatient basis
Colectomy
colectomy due to neoplastic (stage 1) or diverticulosis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Colectomy
colectomy due to neoplastic (stage 1) or diverticulosis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with an indication for scheduled left colectomy due to neoplastic (stage 1) or diverticulitis,
* Patient residing less than 30 minutes from La Rochelle hospital,
* Presence of a companion from the anaesthesia consultation onwards,
* Presence of an attendant at the patient's discharge,
* Perfect understanding of outpatient care, pathology and surgical procedure of the patient and accompanying person,
* Informed of the study.
Exclusion Criteria
* Indication for a straight or transverse colectomy,
* Neoplasia evolution \> stage 1,
* Presence of anticoagulant treatment,
* Intraoperative bleeding \> 500ml,
* Conversion to laparotomy,
* Severe anesthetic complication (Anaphylaxis, Difficult Intubation),
* Persons deprived of their liberty by a judicial or administrative decision,
* Persons of full age who are subject to a legal protection measure,
* Persons unable to consent,
* Persons who are not members of or beneficiaries of a social security scheme,
* Patient's refusal to participate in the study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic
INDUSTRY
Groupe Hospitalier de la Rochelle Ré Aunis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexandre Smirnoff, MD
Role: STUDY_DIRECTOR
Groupe Hospitalier de la Rochelle Ré Aunis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Groupe Hospitalier de la Rochelle Ré Aunis
La Rochelle, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018/P01/280
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.